Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endovanilloid signaling in pain.

Vincenzo Di Marzo1, Peter M Blumberg, Arpad Szallasi

  • 1Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, Comprensorio Olivetti, Edificio 70, 80078 Pozzuoli, Napoli, Italy. vdimarzo@icmib.na.cnr.it

Current Opinion in Neurobiology
|July 26, 2002
PubMed
Summary

Vanilloid receptor type 1 (VR1) plays a key role in pain perception and inflammation. Targeting VR1 offers a promising strategy for developing new pain relief medications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrent basosquamous carcinoma of the forearm, a case report.

JPRAS open·2026
Same author

Cancer pain: current practice and emerging targets.

British journal of pharmacology·2026
Same author

Tooth Pulp Afferents and Transient Receptor Potential (TRP) Ion Channels as Key Regulators of Pulp Homeostasis, Inflammation, and Pain.

International journal of molecular sciences·2026
Same author

Discovery of Dual TRPA1 and TRPV1 Antagonists as Novel Therapeutic Agents for Pain.

Pharmaceuticals (Basel, Switzerland)·2024
Same author

Gastric Carcinogenesis and Potential Role of the Transient Receptor Potential Vanilloid 1 (TRPV1) Receptor: An Observational Histopathological Study.

International journal of molecular sciences·2024
Same author

Discovery of N-(1,4-Benzoxazin-3-one) urea analogs as Mode-Selective TRPV1 antagonists.

Bioorganic & medicinal chemistry letters·2024

Area of Science:

  • Neuroscience
  • Pain Research
  • Molecular Biology

Background:

  • Vanilloid receptor type 1 (VR1) is implicated in pain signaling.
  • VR1 activity is modulated by endogenous factors and inflammatory conditions.
  • Inflammation can increase VR1 sensitivity and expression.

Purpose of the Study:

  • To explore the role of VR1 in pain perception and inflammatory hyperalgesia.
  • To investigate the mechanisms regulating VR1 activity.
  • To assess the therapeutic potential of targeting VR1 for pain management.

Main Methods:

  • Review of recent scientific literature on VR1.
  • Analysis of VR1 regulation by endogenous factors like protein kinase C, bradykinin, and nerve growth factor.
  • Examination of VR1's role in inflammatory conditions and pain models (e.g., VR1 knockout mice, diabetic mice).

Related Experiment Videos

Main Results:

  • VR1 activity is modulated by pH, protein kinase C, and anandamide.
  • Bradykinin and nerve growth factor release VR1 from inhibitory control.
  • Increased VR1 expression and sensitivity are observed during inflammation.
  • VR1 knockout mice exhibit reduced inflammatory hyperalgesia.
  • Anti-VR1 serum ameliorates thermal allodynia and hyperalgesia in diabetic mice.

Conclusions:

  • Endovanilloid signaling via VR1 is crucial for inflammatory pain in humans.
  • Downregulation of VR1 expression or activity presents a viable therapeutic strategy for novel analgesics.
  • Understanding VR1 regulation provides insights into pain mechanisms and drug development.